JPH0278432A - Transparent composition - Google Patents
Transparent compositionInfo
- Publication number
- JPH0278432A JPH0278432A JP1149959A JP14995989A JPH0278432A JP H0278432 A JPH0278432 A JP H0278432A JP 1149959 A JP1149959 A JP 1149959A JP 14995989 A JP14995989 A JP 14995989A JP H0278432 A JPH0278432 A JP H0278432A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- surfactant
- transparent
- lecithin
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 25
- 239000004094 surface-active agent Substances 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000003921 oil Substances 0.000 abstract description 24
- 235000019198 oils Nutrition 0.000 abstract description 24
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract description 20
- 239000000787 lecithin Substances 0.000 abstract description 20
- 235000010445 lecithin Nutrition 0.000 abstract description 20
- 229940067606 lecithin Drugs 0.000 abstract description 20
- 238000010008 shearing Methods 0.000 abstract description 8
- 239000002537 cosmetic Substances 0.000 abstract description 7
- 239000003995 emulsifying agent Substances 0.000 abstract description 7
- 239000006185 dispersion Substances 0.000 abstract description 6
- 230000007794 irritation Effects 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 2
- 235000021302 avocado oil Nutrition 0.000 abstract description 2
- 239000008163 avocado oil Substances 0.000 abstract description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract description 2
- 241000270666 Testudines Species 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- -1 sugar alcohol fatty acid esters Chemical class 0.000 description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 14
- 235000019388 lanolin Nutrition 0.000 description 14
- 229940039717 lanolin Drugs 0.000 description 14
- 238000002834 transmittance Methods 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 238000005342 ion exchange Methods 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 150000003904 phospholipids Chemical class 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 229940042880 natural phospholipid Drugs 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 3
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 241000039951 Lithocarpus glaber Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- 229960001325 triclocarban Drugs 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- ZDWWMDFWLMFCJJ-DNKZHYAASA-N (4s)-4-(dodecanoylamino)-5-(2-octyldodecoxy)-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@@H](CCC(O)=O)C(=O)OCC(CCCCCCCC)CCCCCCCCCC ZDWWMDFWLMFCJJ-DNKZHYAASA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はレシチンのごとき安全性の高い両親媒性物質の
会合体分散液から形成される透明組成物及びこれを含む
外用剤に関する。更に詳しくは、レシチンのごとき安全
性の高い両親媒性物質と可溶化助剤として少量の界面活
性剤との混合により得られる会合体の分散液から形成さ
れ、透明性、経時安定性、安全性に優れた新規な透明組
成物及びこれを含む外用剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a transparent composition formed from an aggregate dispersion of a highly safe amphipathic substance such as lecithin, and an external preparation containing the same. More specifically, it is formed from a dispersion of an aggregate obtained by mixing a highly safe amphiphilic substance such as lecithin with a small amount of surfactant as a solubilization aid, and has excellent transparency, stability over time, and safety. The present invention relates to a novel transparent composition with excellent properties and an external preparation containing the same.
[従来の技術1
皮膚に対する有効物質、生理活性物質及び薬剤等には油
性物質が多く、これらを安定に配合できる透明系の基剤
の開発が望まれている。従来、油性成分を安定に配合し
た透明系を得るには界面活性剤やエタノール等を高濃度
で配合する方法が知られていた。これらの高濃度の配合
は皮膚、眼、粘膜等への刺激を引き起こす場合があった
。[Prior Art 1] Many effective substances for the skin, physiologically active substances, drugs, etc. are oily substances, and it is desired to develop a transparent base that can stably incorporate these substances. Conventionally, in order to obtain a transparent system in which oily components are stably blended, a method of blending surfactants, ethanol, etc. at high concentrations has been known. These high concentration formulations may cause irritation to the skin, eyes, mucous membranes, etc.
[発明が解決しようとする課題I
LL狡青勿澗1漁
これらの刺激性を低減する目的から、合成の界面活性剤
にかわって天然物由来であり安全性の高いレシチンを用
いる方法があるが、レシチンは乳化力、可溶化力が弱い
ために系の高い透明性は得られず、安定性にも乏しい。[Problems to be Solved by the Invention] In order to reduce these irritations, there is a method of using lecithin, which is derived from a natural product and is highly safe, instead of synthetic surfactants. Because lecithin has weak emulsifying and solubilizing power, high transparency of the system cannot be obtained, and it is also poor in stability.
また、粒子径を小さくシ透明性を増すために、高圧乳化
機のごとき強力な1カをかける方法も知られているが、
この方法によっても調製直後の透明性は増すものの安定
性には乏しく透明性を充分に維持することは出来にくく
実使用に耐えない場合が多い。Additionally, in order to reduce the particle size and increase transparency, a method of applying a powerful force such as a high-pressure emulsifier is also known.
This method also increases the transparency immediately after preparation, but the stability is poor and transparency cannot be maintained sufficiently, so it is often not suitable for practical use.
以上のようにレシチン単独では充分な安定性は得られな
いために、レシチンに更にある種の非イオン性界面活性
剤またはエタノールを併用する方法もあるが、完全な透
明系を得るためにはレシチンに対し多量の非イオン性界
面活性剤またはエタノールを必要とする。そして、他の
油性成分を更に共存させるためには必然的に配合する非
イオン性界面活性剤、エタノール星が更に増え、従来技
術と同じ様に刺激性発現が再び問題となる。As mentioned above, sufficient stability cannot be obtained with lecithin alone, so there is a method of combining lecithin with some kind of nonionic surfactant or ethanol, but in order to obtain a completely transparent system, lecithin Requires a large amount of nonionic surfactant or ethanol. In order to further coexist other oily components, the amount of nonionic surfactant and ethanol added will inevitably increase, and as with the prior art, irritation will once again become a problem.
このように油性成分を配合した安定な透明系を得るには
幾つかの方法があるものの、いずれの方法もまだ実用に
耐え得るものではなかった。Although there are several methods for obtaining a stable transparent system containing an oily component, none of the methods has yet been suitable for practical use.
定朋授上刃
本発明はこれらの問題点を解決すべく鋭意研究を行った
結果、レシチンのごとき両親媒性物質と少量の界面活性
剤とを水中で均一に分散させた後ホモミキサー等の剪断
力を有する乳化機で処理することにより刺激性発現の心
配のない程度の少量の界面活性剤で油性成分を安定に配
合した新規な透明組成物を得るに至った。As a result of intensive research to solve these problems, the present invention was developed by uniformly dispersing an amphipathic substance such as lecithin and a small amount of surfactant in water, and then using a homomixer etc. By processing with an emulsifying machine having shearing force, we have obtained a new transparent composition in which an oily component is stably blended with a small amount of surfactant that does not cause irritation.
[課題を解決するための手段]
すなわち本発明は、
(1)両親媒性物質と界面活性剤と油性成分と水とを含
む透明組成物。[Means for Solving the Problems] That is, the present invention provides: (1) A transparent composition containing an amphiphilic substance, a surfactant, an oily component, and water.
(2)両親媒性物質と界面活性剤と油性成分と水とを含
む混合物に強力な剪断力処理をして成る請求項1記載の
透明組成物。(2) The transparent composition according to claim 1, which is obtained by subjecting a mixture containing an amphiphilic substance, a surfactant, an oily component, and water to a strong shear force treatment.
(3)油性成分1重量部に対し10重量部以下の界面活
性剤を含む請求項1記載の透明組成物。(3) The transparent composition according to claim 1, which contains 10 parts by weight or less of a surfactant per 1 part by weight of the oily component.
(4)請求項1乃至3記載の透明組成物を含む外用前り
。(4) An external preparation comprising the transparent composition according to any one of claims 1 to 3.
である。It is.
これらは、例えばレシチンのごとき安全性の高い両親媒
性物質と、可溶化助剤として少量の界面活性剤との混合
分散液を通常化粧料を製造するのに使用されるホモミキ
サー等の剪断力を有する乳化機で処理することにより得
られる透明性、経時安定性及び安全性にすくれな新規な
透明組成物及びこれを含む外用剤を得るものである。These methods are applied using shearing force such as a homomixer, which is normally used to produce cosmetics, to prepare a mixed dispersion of a highly safe amphiphilic substance such as lecithin and a small amount of surfactant as a solubilization aid. The present invention aims to obtain a novel transparent composition that has excellent transparency, stability over time, and safety, and an external preparation containing the same, which can be obtained by processing with an emulsifying machine having the above-mentioned technology.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明において両親媒性物質とは疎水基と親水基を同一
分子中に含む性質を有する物質であり、例えば、レシチ
ン、ジアルキルジメチルアンモニウムクロリドなどの第
四級アンモニウム塩型の合成脂質、第四級アンモニウム
塩と高級アルコールとの?捏合物などがあげられる。こ
の中で、レシチンとは大豆レシチン、卵黄レシチン等の
天然リン脂質、合成リン脂質、あるいは天然リン脂質に
水素添加を行ったものなど、任意のリン脂質を利用する
ことができる。天然のリン脂質は全て不飽和脂肪酸を含
んでいるため、上記天然リン脂質の不飽和脂肪酸を水素
で飽和した水素添加リン脂質を使用するのがより効果的
である。合成リン脂質も高価ではあるが使用可能である
。In the present invention, an amphipathic substance is a substance that has the property of containing a hydrophobic group and a hydrophilic group in the same molecule, such as lecithin, quaternary ammonium salt type synthetic lipids such as dialkyldimethylammonium chloride, Ammonium salt and higher alcohol? Examples include kneaded foods. Among these, lecithin can be any phospholipid such as natural phospholipids such as soybean lecithin and egg yolk lecithin, synthetic phospholipids, or hydrogenated natural phospholipids. Since all natural phospholipids contain unsaturated fatty acids, it is more effective to use hydrogenated phospholipids in which the unsaturated fatty acids of the natural phospholipids are saturated with hydrogen. Synthetic phospholipids can also be used, although they are expensive.
リン脂質の代表例としては、レシチン、ホスファチジル
エタノールアミン、ホスファチジン酸、ホスファチジル
イノシトール、ホスファチジルセリン、ホスファチジル
コリン、ホスファチジルグリセロール、スフィンゴミエ
リン、カルシオリピン等を挙げることができる。さらに
、これらに常法に従い水素添加したものが挙げられる。Representative examples of phospholipids include lecithin, phosphatidylethanolamine, phosphatidic acid, phosphatidylinositol, phosphatidylserine, phosphatidylcholine, phosphatidylglycerol, sphingomyelin, calciolipin, and the like. Further examples include those obtained by hydrogenating these in accordance with conventional methods.
特に大豆レシチン、卵黄レシチン、コーンレシチン、綿
実油レシチン、ナタネレシチン等を水素添加した水素添
加天然レシチンが好適に使用される。In particular, hydrogenated natural lecithin obtained by hydrogenating soybean lecithin, egg yolk lecithin, corn lecithin, cottonseed oil lecithin, rapeseed lecithin, etc. is preferably used.
本発明において界面活性剤とは、非イオン性活性剤、イ
オン性活性剤(カチオン、アニオン、両性)のいずれで
もよいが、安全性の面から通常化粧料に用いられる非イ
オン性活性剤が望ましい。In the present invention, the surfactant may be either a nonionic surfactant or an ionic surfactant (cationic, anionic, or amphoteric), but from the viewpoint of safety, nonionic surfactants commonly used in cosmetics are preferred. .
更に詳しくは、蔗糖脂肪酸エステル、マルチ) −ル脂
肪酸エステルなどの糖あるいは糖アルコール脂肪酸エス
テル、ソルビタン脂肪酸エステル、グリセリン脂肪酸エ
ステル、ポリグリセリン脂肪酸エステル、プロピレング
リコール脂肪酸エステル、ポリオキシエチレンソルビタ
ン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪
酸エステル、ポリオキシエチレングリセリン脂肪酸エス
テル、ポリエチレングリコール脂肪酸エステル、ポリオ
キシエチレンアルキルエーテル、ポリオキシエチレンフ
ィトステロールエーテル、ポリオキシエチレンポリオキ
シプロピレンアルキルエーテル、ポリオキシエチレンア
ルキルフェニルエーテル、ポリオキシエチレンコレスタ
ノールエーテル、ポリオキシエチレンヒマシ油、ポリオ
キシエチレン硬化ヒマシ油、ポリオキシエチレンミツロ
ウ誘導体、ポリオキシエチレンラノリン誘導体、ポリオ
キシエチレンアルキルアミン、ポリオキシエチレンアル
キルアミド等があげられる。More specifically, sugar or sugar alcohol fatty acid esters such as sucrose fatty acid esters, multi-yl fatty acid esters, sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, propylene glycol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxy Ethylene sorbitan fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene phytosterol ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene cholestanol Examples include ether, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene beeswax derivatives, polyoxyethylene lanolin derivatives, polyoxyethylene alkylamine, polyoxyethylene alkylamide, and the like.
本発明において、系中に配合する油状成分は液状油分、
固型油分、半固型油分または水に難溶性の物質のいずれ
でもよく、例えばアボガド油、ツハキ油、タードル油、
マカデミアナツツ油、トウモロコシ油、ミンク油、オリ
ーブ油、ナタネ油、卯黄油、ゴマ油、パーシック油、小
麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワ
ー油、綿実油、月見草油、エノ油、大豆油、落花生油、
茶実油、カヤ油、コメヌカ油、シナギリ油、日本;1−
り油、ホホバ油、胚芽油、トリグリセリン、トリオクタ
ン酸グリセリン、トリイソパルミチン酸グリセリン等の
液体油脂、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パー
ム油、牛脂、羊脂、硬化牛脂、パーム核油、肝脂、牛骨
脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒ
マシ油等の固型油脂、ミツロウ、カンデリラロウ、綿ロ
ウ、力Av−J−ハロウ、ヘイベリーロウ、イボクロウ
、鯨ロウ、モノクンロウ、ヌカ[2つ、ラノリン、カポ
ックロウ、酢酸ラノリン、液状ラノリン、サトウキビロ
ウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル
、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラ
ック[1つ、POEラノリンアルニ1−ルエーテル、P
OEラノリンアルコールアセテート、ラノリン脂肪酸ポ
リエチレングリコール、P OIE 水$ 添)Jlラ
ノリンアルコールエーテル等のロウ類、流動パラフィン
、オシケライト、スクワレン、プリスタン、パラフィン
、セレシン、スクワラン、ワセリン、マイクロクリスタ
リンワックス等の炭化水素、ミリスチン酸イソプロピル
、オクタン酸セチル、ミリスチン酸オクチルドデシル、
パルミチン酸イソプロピル、ステアリン酸ブチル、ラウ
リン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸
デシル、ジメチルオクタン酸へキシルデシル、乳酸セチ
ル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソ
セチル、イソステアレン酸イソセチル、12−ヒドロキ
システアリル酸コルステリル、ジー2−エチルヘキシル
酸エチレングリコール、ジペンタエリスリトール脂肪酸
エステル、モノイソステアリン酸N−アルキルグリコー
ル、シカプリン酸ネオペンチルグリコール、リンゴ酸ジ
イサステアリル、ジー2−ヘプチルウンデカン酸グリセ
リン、トリー2−エチルヘキシル酸トリメチロールプロ
パン、トリイソステアリン酸トリメチロールプロパン、
テトラ−2−エチルヘキシル酸ペンタエリスリトール、
トリー2−エチルヘキシル酸グリセリン、トリイソステ
アリン酸トリメチロールプロパン、セチル−2−エチル
ヘキサノエート、2−エチルヘキシルパルミテート、ト
リミリスチン酸グリセリン、トリー2−ヘプチルウンデ
カン酸グリセライド、ヒマシ油脂肪酸メチルエステル、
オレイン酸オイル、セトステアリルアルコール、アセト
グリセライド、パルミチン酸−2−ヘプチルウンデシル
、アジピン酸ジイソプロピル、N−ラウロイル−し−グ
ルタミン酸−2−オクチルドデシルエステル、アジピン
酸ジー2−へブチルウンデシル、エチルラウレート、セ
ハチン酸ジー2−エチルヘキシル、ミリスチン酸−2−
ヘキシルデシル、パルミチン酸−2−へキシルデシル、
アジピン酸−2−へキシルデシル、セハチル酸ジイソプ
ルピル、コハク酸−2−エチルヘキシル、酢酸エチル、
酢酸ブチル、酢酸アミル、クエン酸トリエチル等の合成
エステル、ラウリン酸、ミリスチン酸、パルミチン酸、
ステアリン酸、ヘヘン酸(ベヘニル)酸、オレイン酸、
12−ヒドロキシステアリン酸、ウンデカン酸、トール
酸、ラノリン脂肪酸、イソステアリン酸、リノール酸、
リルイン酸、エイコサペンクエン酸等の高級脂肪酸、ラ
ウリンアルコール、セチルアルコール、ステアリルアル
コール、へヘニルアルコ−ル、ミリスチルアルコール、
オレイルアルコール、セトステアリルアルコール、モノ
ステアリルグリセレンエーテル(ハチルアルコール)、
2−デンルテトラデシノール、ラノリンアルコール、コ
レステロール、フィトステロール、ヘキシルドデカノー
ル、イソステアリルアルコール、オクチルドデカノール
等の直鎖、分岐高級アルコール、ビタミンA及びその誘
導体、ビタミンD及びその誘導体、ビタミンE及びその
誘導体、ビタミンK及びその誘導体等のビタミン類、ス
テロール類、天然及び合成の香料等があげられ、このう
ち融点が常温以下を液状油分、融点が常温以上を固型、
半固型油分と区別される。In the present invention, the oily components blended into the system are liquid oil,
It may be a solid oil, a semi-solid oil, or a substance that is poorly soluble in water, such as avocado oil, thorn oil, turd oil,
Macadamia oil, corn oil, mink oil, olive oil, rapeseed oil, feral oil, sesame oil, persic oil, wheat germ oil, sasanquat oil, castor oil, linseed oil, safflower oil, cottonseed oil, evening primrose oil, eno oil, soybean oil , peanut oil,
Tea seed oil, Kaya oil, Rice bran oil, Shinagiri oil, Japan; 1-
Liquid fats and oils such as lily oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, glycerin triisopalmitate, cacao butter, coconut oil, horse tallow, hydrogenated coconut oil, palm oil, beef tallow, mutton tallow, hydrogenated beef tallow, Solid oils and fats such as palm kernel oil, liver fat, beef bone fat, Japanese oak kernel oil, hydrogenated oil, beef leg fat, Japanese oak, hydrogenated castor oil, beeswax, candelilla wax, cotton wax, Chikara Av-J-Hallow, Hayberry wax, Ibokuro , spermaceti wax, monokunwa, bran [2 pieces, lanolin, kapok wax, acetic acid lanolin, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, jojoba wax, hard lanolin, shellac [1 piece, POE lanolin alni 1 piece] -Luether, P
OE lanolin alcohol acetate, lanolin fatty acid polyethylene glycol, POIE water $) Jl Waxes such as lanolin alcohol ether, hydrocarbons such as liquid paraffin, osikelite, squalene, pristane, paraffin, ceresin, squalane, vaseline, microcrystalline wax, Isopropyl myristate, cetyl octoate, octyldodecyl myristate,
Isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, colsteryl 12-hydroxystearate, Ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol capriate, diisastearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexylate. , trimethylolpropane triisostearate,
pentaerythritol tetra-2-ethylhexylate,
Tri-2-ethylhexylic acid glycerin, triisostearate trimethylolpropane, cetyl-2-ethylhexanoate, 2-ethylhexyl palmitate, trimyristate glycerin, tri-2-heptyl undecanoic acid glyceride, castor oil fatty acid methyl ester,
Oleic acid oil, cetostearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, diisopropyl adipate, N-lauroyl-glutamic acid-2-octyldodecyl ester, di-2-hebutylundecyl adipate, ethyllau rate, di-2-ethylhexyl cehatate, myristic acid-2-
hexyldecyl, 2-hexyldecyl palmitate,
2-hexyldecyl adipate, diisopropyl cehatylate, 2-ethylhexyl succinate, ethyl acetate,
Synthetic esters such as butyl acetate, amyl acetate, triethyl citrate, lauric acid, myristic acid, palmitic acid,
stearic acid, hehenic acid (behenyl) acid, oleic acid,
12-hydroxystearic acid, undecanoic acid, tolic acid, lanolin fatty acid, isostearic acid, linoleic acid,
Higher fatty acids such as riluic acid and eicosapene citric acid, lauric alcohol, cetyl alcohol, stearyl alcohol, hehenyl alcohol, myristyl alcohol,
Oleyl alcohol, cetostearyl alcohol, monostearylglycerenether (hatyl alcohol),
Linear and branched higher alcohols such as 2-denlutetradecinol, lanolin alcohol, cholesterol, phytosterols, hexyldodecanol, isostearyl alcohol, and octyldodecanol, vitamin A and its derivatives, vitamin D and its derivatives, vitamin E and Derivatives thereof, vitamins such as vitamin K and its derivatives, sterols, natural and synthetic fragrances, etc. Of these, those with melting points below room temperature are liquid oils, and those with melting points above room temperature are solids.
Distinguished from semi-solid oils.
また、水に難溶性の物質としては、ユビキノン、ビタミ
ンP等のビタミン類、塩酸クロルヘキシジン、トリクロ
ロカルバニリド、イメガッサンDP300などの殺菌剤
、酢酸デキサメタシン等の薬剤、パラアミノ安息香酸(
以下PABAと略す)、N。Substances that are poorly soluble in water include vitamins such as ubiquinone and vitamin P, disinfectants such as chlorhexidine hydrochloride, trichlorocarbanilide, and Imegassan DP300, drugs such as dexamethacin acetate, and para-aminobenzoic acid (
(hereinafter abbreviated as PABA), N.
N−ジメチルPABAオクチルエステルなどの紫外線吸
収剤、パラベン等の防腐剤等が挙げられる本発明におけ
る両親媒性物質、界面活性剤及び油性成分の配合量は、
両親媒性物質1重量部に対して界面活性剤0.001〜
100重量部が望ましく、更に好ましくは0.01〜1
0重量部が望ましく、さらに0.01〜5重量部が最も
好ましい。 また、油性成分1重量部に対し、両親媒性
物質と界面活性剤との合計量は50重量部以下が望まし
く、更に好ましくは20重置部以下が望ましい。界面活
性剤10重量部以下特に1重量部以下でも透明性の高い
組成物が得られることが特徴である。The amounts of amphipathic substances, surfactants and oily components in the present invention, including ultraviolet absorbers such as N-dimethyl PABA octyl ester, preservatives such as parabens, etc., are as follows:
0.001 to 1 part of surfactant per 1 part by weight of amphiphile
100 parts by weight is desirable, more preferably 0.01 to 1
It is preferably 0 parts by weight, and most preferably 0.01 to 5 parts by weight. Further, the total amount of the amphiphilic substance and surfactant is desirably 50 parts by weight or less, more preferably 20 parts by weight or less, per 1 part by weight of the oily component. A feature is that a highly transparent composition can be obtained even with 10 parts by weight or less, especially 1 part by weight or less, of the surfactant.
本発明の透明組成物は、以下の必須成分を有する混合分
散液をホモミキサー等通常化粧品の製造に使用されるよ
うな乳化機で処理することにより、得られる。本願発明
の透明組成物はホモミキサーよりも強力な剪断力をかけ
られる乳化機、例えばマントンボウリン、フレンチプレ
ス、コロイドミル、マイクロフルイダイザー、超音波乳
化機など、強力な剪断力で処理することにより、その透
明性、安全性、安定性がさらに増す。The transparent composition of the present invention can be obtained by treating a mixed dispersion containing the following essential components with an emulsifying machine such as a homomixer that is commonly used in the production of cosmetics. The transparent composition of the present invention can be processed using an emulsifier that can apply a stronger shearing force than a homomixer, such as a Manton Bowlin, French press, colloid mill, microfluidizer, or ultrasonic emulsifier. , its transparency, safety and stability will further increase.
本発明において強力な剪断力処理とは、通常化)用品な
どの製造に用いられるミキサー(ホモミキサー、ディス
パーミキサー、プロペラ撹拌機など)よりも強力なシェ
アーをかけられる乳化機で処理することを言い、マント
ンボウリン、フレンチプレス、マイクロフルイダイザー
等の高圧ホモジナイザーで500psi以上さらに好ま
しくは2,000 psi以上、コロイドミルで1.O
OOrpmさらに好ましくは5.000 rpm以上ま
たは、超音波乳化機等で処理することを言う。In the present invention, strong shearing force processing refers to processing using an emulsifying machine that can apply a stronger shear than mixers (homogen mixers, disper mixers, propeller agitators, etc.) used in the production of regular products. , Manton Bowlin, French press, microfluidizer, or other high-pressure homogenizer at 500 psi or more, preferably 2,000 psi or more, or a colloid mill at 1. O
OOrpm, more preferably 5.000 rpm or more, or processing using an ultrasonic emulsifier or the like.
本発明に係わる剪断力処理は系全量を行ってもよいし、
場合によっては一部を処理し、その後に水あるいは多価
アルコール等の他の配合物により希釈してもよい。The shearing force treatment according to the present invention may be performed on the entire system, or
Optionally, a portion may be treated and then diluted with water or other formulations such as polyhydric alcohols.
本発明において、本乳化前の予備乳化を行うにあたり、
油分または難溶性物質を配合する際に次のような工程を
とると簡便である。すなわち、まず両親媒性物質、界面
活性剤及び油性物質の一部または全部を水性溶媒に分子
状に分散または溶解する。このとき場合によっては少量
の水を加えてもよい。この際、加温及び/またはホモミ
キサーなどで処理を行うとよい。この際、徐添中及び/
または除垢後にプロペラ式撹拌機、ホモミキサーなどで
系を均一にするとよい。In the present invention, when performing preliminary emulsification before main emulsification,
When blending oil or poorly soluble substances, it is convenient to take the following steps. That is, first, part or all of the amphiphilic substance, surfactant, and oily substance are dispersed or dissolved in molecular form in an aqueous solvent. At this time, a small amount of water may be added depending on the case. At this time, it is preferable to perform treatment by heating and/or using a homomixer. At this time, during gradual addition and/
Alternatively, after removing scale, it is recommended to homogenize the system using a propeller type stirrer, homomixer, etc.
ここでいう水性溶媒としては、例えばエチレングリコー
ル、プロピレングリコール、1.3−ブチレングリコー
ル、ジプロピレングリコール、グリセリン、ジグリセリ
ン、トリグリセリン、テトラグリセリンなどのポリグリ
セリン、グルコース、”フルドース、マルチトール、蔗
糖、フルクトース、キシリトール、イノシトール、ペン
タエリスリトール、ソルビトール、マルトトリオース、
R粕分解糖、澱粉分解槽還元アルコールなどが挙げられ
る。Examples of the aqueous solvent here include polyglycerols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, dipropylene glycol, glycerin, diglycerin, triglycerin, and tetraglycerin, glucose, "fuldose, maltitol, and sucrose." , fructose, xylitol, inositol, pentaerythritol, sorbitol, maltotriose,
Examples include R-lees decomposition sugar and starch decomposition tank reduced alcohol.
ここでいう水相としては、例えばビタミンB群、ビタミ
ンC及びその誘導体、パントテン酸及びその誘導体、ビ
オチン等のビタミン類、などの水溶性活性物質、グルタ
ミン酸ナトリウム、アルギニン、アスパラギン酸、クエ
ン酸、酒石酸、乳酸、などの緩衝剤、EDTAなどのキ
レート刑などの紫外線吸収剤、各種色素の一種または二
種以上の水溶ン夜があげられる。The aqueous phase here includes, for example, water-soluble active substances such as B vitamins, vitamin C and its derivatives, pantothenic acid and its derivatives, vitamins such as biotin, monosodium glutamate, arginine, aspartic acid, citric acid, and tartaric acid. Examples include buffering agents such as , lactic acid, ultraviolet absorbers such as chelating agents such as EDTA, and water-soluble dyes containing one or more of various dyes.
以上のようにして本発明の透明組成物が得られる。The transparent composition of the present invention is obtained in the manner described above.
なお、ここで本発明のいう透明とは、分光光度計700
nmで測定したとき蒸留水の透過率を100%とした場
合その透過率80%以上のものをいう。Note that the term "transparent" in the present invention refers to the spectrophotometer 700.
If the transmittance of distilled water is 100% when measured in nm, the transmittance is 80% or more.
以上の透明組成物は、その特性が要求されるあらゆる分
野で利用可能であり、その用途は限定されないが、特に
は、請求項4記載の外用剤として利用されるのが最適で
ある。The transparent composition described above can be used in any field where its properties are required, and its use is not limited, but it is most suitable for use as an external preparation according to claim 4.
なお、外用剤とは化粧品、医薬品、医薬部外品などを言
う。Note that external preparations include cosmetics, pharmaceuticals, quasi-drugs, etc.
[実施例]
次に本発明の一層の理解のために、実施例をあげて更に
詳細に説明するが、本発明がこれら実施例によって限定
されるものではないことはいうまでもない。[Examples] Next, in order to further understand the present invention, Examples will be given and explained in more detail, but it goes without saying that the present invention is not limited to these Examples.
実施例1〜3及び比較例1
表−1に示す成分1)〜5)を加熱溶解しホモミキサー
により系を均一にした後、6〕を徐々添加し、マントン
ボウリンにより加圧乳化した。Examples 1 to 3 and Comparative Example 1 After heating and dissolving components 1) to 5) shown in Table 1 and making the system homogeneous using a homomixer, 6] was gradually added and emulsified under pressure using a Manton Bowlin.
実施例4〜6及び比較例2
実施例1〜3及び比較例1のマントンボウリン処理をホ
モミキサー処理に変えた以外は同様にして試作を行った
。Examples 4 to 6 and Comparative Example 2 Trial production was carried out in the same manner as in Examples 1 to 3 and Comparative Example 1 except that the Manton-Bowlin treatment was changed to the homomixer treatment.
実施例1〜6及び比較例1〜2の安全性、透明性及び安
定性の評価結果を表−2に示すが、本発明の実施例は透
明性が高く、安全性、安定性も非常に良好な評価を得た
。The evaluation results of safety, transparency, and stability of Examples 1 to 6 and Comparative Examples 1 to 2 are shown in Table 2, and the examples of the present invention have high transparency and are very safe and stable. It received good reviews.
なお、各実施例、比較例で採用した試験法、評価法は以
下のとおりである。The test methods and evaluation methods employed in each example and comparative example are as follows.
支仝七二パネル30名の前腕に実施例及び比較例の組成
物を塗布し、■昼夜閉塞パッチテストを行い、評価した
。The compositions of Examples and Comparative Examples were applied to the forearms of 30 72 support panelists, and a day/night occlusion patch test was conducted and evaluated.
L皿上: 700nmにおける透過率を測定した。蒸留
水の透過率を100%としたときの実施例及び比較例の
組成物の透過率を評価した。On L dish: Transmittance at 700 nm was measured. The transmittance of the compositions of Examples and Comparative Examples was evaluated when the transmittance of distilled water was set as 100%.
支足上: 1力月後の安定性を視覚的に評価した。On the support foot: Stability was visually evaluated after 1 month.
表−1
表−2
実施例7.8
表−3に示す成分1)〜5)を加熱熔解し、ホモミキサ
ーにより、系を均一にした後、6)を徐々に添加し、マ
ントンボウリンにより加圧乳化した(以下余白)
表−3
実施例7.8の安全性1.透明性及び安定性の評価テス
トを実施例1と同様の方法で行った結果を表−3に示し
た。透明性が高く安全性、安定性も非常に良好なことが
分かる。Table 1 Table 2 Example 7.8 Ingredients 1) to 5) shown in Table 3 were melted by heating and the system was made homogeneous using a homomixer, then 6) was gradually added and processed using a Manton Bowlin. Compressed emulsified (hereinafter blank) Table 3 Safety of Example 7.8 1. Transparency and stability evaluation tests were conducted in the same manner as in Example 1, and the results are shown in Table 3. It can be seen that it has high transparency, safety, and stability.
実施例9
重量部
1)1.3−ブチレングリコール 10.0
2)水添卯黄レシチン 1.83
) POE(60)硬化ヒマシ油 0.2
4)スクワラン 0.25)ビ
タミンEアセテ−) 0.056)メ
チルパラベン 0.17)イオン
交換水 87.628)アスコル
ビン酸 0.031〜6)を70゛
C加温後、ホモミキサーにより撹拌しながら7〜8)を
徐添した。その後マントンボウリンにより 6,0OO
psiで10回処理を行い、透過率90%以上、室温下
で6力月以上安定な水性透明組成物を得た。Example 9 Parts by weight 1) 1.3-butylene glycol 10.0
2) Hydrogenated Uoki lecithin 1.83
) POE (60) Hydrogenated castor oil 0.2
4) Squalane 0.25) Vitamin E acetate) 0.056) Methylparaben 0.17) Ion-exchanged water 87.628) Ascorbic acid 0.031-6) After heating to 70°C, while stirring with a homomixer 7 to 8) were gradually added. After that, 6,0OO by Manton Bowlin.
The treatment was carried out 10 times at psi to obtain an aqueous transparent composition with a transmittance of 90% or more and stable at room temperature for 6 months or more.
実施例10
重量部
1)グリセリン 10.02)
プロピレングリコール 5.03)ジ
パルミトイルホスファチジルコリン 2.04 )
POE(20)ソルビタンモノオレイン酸 2.0
エステル
5)イソオクタン酸セチル 0.16
)オクチルジメチルPABA O,3
7)ブチルパラベン 0.18)
イオン交換水 20.09)イ
オン交換水 60.51〜7)
を70°C加温後、ホモミキサーにより攪拌しなから8
)を徐添した。その後、超音波乳化機にて透明感がでる
まで処理し、室温下で9)を添加して透過率90%以上
、室温下で6力月以上安定な紫外線吸収効果を有する水
性透明化粧料を得た。Example 10 Part by weight 1) Glycerin 10.02)
Propylene glycol 5.03) Dipalmitoylphosphatidylcholine 2.04)
POE (20) Sorbitan monooleic acid 2.0
Ester 5) Cetyl isooctanoate 0.16
) Octyldimethyl PABA O,3
7) Butylparaben 0.18)
Ion exchange water 20.09) Ion exchange water 60.51-7)
After heating to 70°C, stir with a homomixer.
) was gradually added. After that, it is treated with an ultrasonic emulsifier until it becomes transparent, and 9) is added at room temperature to produce a water-based transparent cosmetic that has a transmittance of 90% or more and a stable UV absorption effect of 6 months or more at room temperature. Obtained.
実施例11
重量部
1)プロピレングリコール 15.02
)セチルトリメチル 1.5アン
モニウムクロライド
3)水添大豆レシチン 3.04
)流動パラフィン 2.05)
イオン交換水 20.06)イ
オン交換水 58.51〜4)
を70°C加温後、ホモミキサーにより撹拌しなから5
)を添加した。その後、マントンボウリンにより 8
、0OOps iで5回処理を行い、室温下で6)を添
加して透過率90%以上、室温下で6力月以上安定な毛
髪透明リンス剤を得た。Example 11 Part by weight 1) Propylene glycol 15.02
) Cetyltrimethyl 1.5 ammonium chloride 3) Hydrogenated soybean lecithin 3.04
) Liquid paraffin 2.05)
Ion exchange water 20.06) Ion exchange water 58.51-4)
After heating to 70°C, stir with a homomixer.
) was added. Later, by Manton Bowlin 8
, 0OOps i five times, and 6) was added at room temperature to obtain a transparent hair rinse agent with a transmittance of 90% or more and stable for 6 months or more at room temperature.
なお、3)を除き、6)を61゜5重量部に変えた以外
は全く同じ方法で得られたリンス剤は、透明性が低く、
安定性も低いものであった。In addition, the rinse agent obtained by the same method except for 3) and changing 6) to 61°5 parts by weight had low transparency;
Stability was also low.
実施例12
重量部
1)グリセリン 5.02)水添
大豆レシチン 1.03 ) PO
E(14)−2−オクチルドデシルエーテル2.04)
酢酸デキサメタシン 0 、0255)
イソオクタン酸セチル 0.56)イオ
ン交換水 91.4751〜5)
を70°c 710温後、ホモミキサーにより攪拌しな
から6)を添加した。その後、マントンボウリンにより
5,000psiで10回処理を行い、透過率90%以
上、室温下で6力月以上安定な抗炎症作用を有する透明
外用剤を得た。Example 12 Parts by weight 1) Glycerin 5.02) Hydrogenated soybean lecithin 1.03) PO
E(14)-2-octyldodecyl ether 2.04)
Dexamethacin acetate 0,0255)
Cetyl isooctanoate 0.56) Ion exchange water 91.4751-5)
After heating at 70°C and 710°C, 6) was added while stirring with a homomixer. Thereafter, it was treated with Manton-Bourin 10 times at 5,000 psi to obtain a transparent external preparation having a transmittance of 90% or more and an anti-inflammatory effect that was stable for 6 months or more at room temperature.
実施例13
重量部
1 ) 1.3−ブチレングリコール 10
.02)ジパルミトイルホスファチジルコリン 1.[
]3 ) POE(10)コレスタノールエーテル
1.04 ) 3,4.4’ トリクロロカルバニリド
0.015)イソオクタン酸セチル
0.26)メチルパラベン
0.17〕イオン交換水 20
.08)イオン交換水 67.6
91〜6)を70’C加温後、ホモミキサーにより攪拌
しなから7)を添加した。その後、マントンボウリンに
より?、000ρsiで10回処理を行い、室温下で8
)を添加して透過率90%以上、室温下で6力月以上安
定な抗アクネ効果を有する透明外用剤を得た。Example 13 Parts by weight 1) 1.3-butylene glycol 10
.. 02) Dipalmitoylphosphatidylcholine 1. [
]3) POE (10) Cholestanol ether
1.04) 3,4.4' trichlorocarbanilide 0.015) Cetyl isooctanoate
0.26) Methylparaben
0.17] Ion exchange water 20
.. 08) Ion exchange water 67.6
After heating 91-6) to 70'C, 7) was added while stirring with a homomixer. Then by Manton Bowlin? , 000ρsi 10 times, and 8
) was added to obtain a transparent external preparation having a transmittance of 90% or more and an anti-acne effect that was stable for 6 months or more at room temperature.
実施例14
重量部
1 ) 1.3−ブチレングリコール 1
0.02)水添大豆レシチン 2.
03 ) POE(60)硬化ヒマシ油
2.04)オリーブ油 1
.05)ビタミンAパルミテート 0.0
56)メチルパラベン 0.17
)イオン交換水 84.851〜
6)を70°C加温後、ホモミキサーにより撹拌しなか
ら7)を徐添した。その後、フレンチプレスにて20
、000ρsiで10回処理し、透過率90%以上、室
温下で6力月以上安定な水性透明組成物を得た。Example 14 Part by weight 1) 1.3-butylene glycol 1
0.02) Hydrogenated soybean lecithin 2.
03) POE (60) hydrogenated castor oil
2.04) Olive oil 1
.. 05) Vitamin A palmitate 0.0
56) Methylparaben 0.17
) Ion exchange water 84.851~
After heating 6) to 70°C, 7) was gradually added while stirring with a homomixer. After that, use a French press for 20
.
実施例15
重量部
l)グリセリン 10.02)1
.3−ブチレングリコール 10.03)水
添大豆レシチン 1.54 ) P
OE(60)硬化ヒマシ油 0.55)
流動パラフィン 0.56)ビタ
ミンEアセテート 0.057)メチル
パラベン 0.18)イオン交換
水 77.351〜7)を70°
C加温後、ホモミキサーにより攪拌しながら、8)を徐
添した、その後コロイドミルにより、15.OOOrp
mで5回処理し、透過率90%以上、室温下で6ケ月以
上安定な水性透明組成物を得た。Example 15 Part by weight l) Glycerin 10.02) 1
.. 3-Butylene glycol 10.03) Hydrogenated soybean lecithin 1.54) P
OE (60) hydrogenated castor oil 0.55)
Liquid paraffin 0.56) Vitamin E acetate 0.057) Methylparaben 0.18) Ion exchange water 77.351~7) at 70°
After heating C, 8) was gradually added while stirring with a homomixer, and then 15. was added with a colloid mill. OOOrp
A transparent aqueous composition having a transmittance of 90% or more and stable for 6 months or more at room temperature was obtained.
実施例16
重量部
1)グリセリン 10.02)ジ
パルミトイルホスファチジルコリン0.53 ) PO
E(10)コレスタノールエーテル 1.54)塩酸
クロルヘキシジン 0.055)イソオ
クタン酸セチル 0.56)イオン交換
水 87.451〜5)を70°
Cに加温後、プロペラ攪拌機により撹拌しなから6)を
除垢した。Example 16 Parts by weight 1) Glycerin 10.02) Dipalmitoylphosphatidylcholine 0.53) PO
E (10) Cholestanol ether 1.54) Chlorhexidine hydrochloride 0.055) Cetyl isooctanoate 0.56) Ion exchange water 87.451~5) at 70°
After heating to C, 6) was removed while stirring with a propeller stirrer.
その後、ホモミキサ−10,OOOrpmで10分間処
理し、透過率80%以上室温で6ケ月以上安定な抗菌作
用を有する透明外用剤を得た。Thereafter, it was treated with Homomixer 10, OOOrpm for 10 minutes to obtain a transparent external preparation having a transmittance of 80% or higher and an antibacterial effect that is stable at room temperature for 6 months or more.
実施例17
重量部
1)グリセリン 5.02)水
添大豆レシチン 2.03 ) P
OE(16)−2−オクチルドデシルエーテル 0.1
4)ビタミンEアセテート 0.55)
イオン交換水 92.41〜4)
を70°C加温後、ホモミキサーにより撹拌しなから5
)を添加した。その後、マントンボウリンにより5,0
OQpsiで10回処理を行い、透過率90%以上、室
温で6力月以上安定な水性透明組成物を得た。Example 17 Parts by weight 1) Glycerin 5.02) Hydrogenated soybean lecithin 2.03) P
OE(16)-2-octyldodecyl ether 0.1
4) Vitamin E acetate 0.55)
Ion exchange water 92.41~4)
After heating to 70°C, stir with a homomixer.
) was added. Then 5,0 by Manton Bowlin
The treatment with OQpsi was performed 10 times to obtain an aqueous transparent composition with a transmittance of 90% or more and stable at room temperature for 6 months or more.
[発明の効果]
請求項1乃至3記載の本発明の透明組成物は、レシチン
のごとき安全性の高い両親媒性物質と可溶化助剤として
少量の界面活性剤との会合体分散液を好ましくは強力な
剪断力で処理することにより得られる透明性、経時安定
性、安全性に優れた新規な透明組成物である。特に、油
性成分1重量部に対し、界面活性剤10重量部以下、特
に1重量部以下でも目的の油性成分を安定且つ透明に配
合できるので、界面活性剤を多量に配合した場合に起こ
る刺激性発現を回避することができ安全性に極めて優れ
ている。[Effects of the Invention] The transparent composition of the present invention according to claims 1 to 3 is preferably an aggregate dispersion of a highly safe amphiphilic substance such as lecithin and a small amount of a surfactant as a solubilization aid. is a novel transparent composition that can be obtained by treatment with strong shearing force and has excellent transparency, stability over time, and safety. In particular, the desired oily component can be stably and transparently blended with 10 parts by weight or less, particularly 1 part by weight or less, of the surfactant per 1 part by weight of the oily component, so it is possible to prevent irritation that may occur when a large amount of surfactant is blended. It is extremely safe as it can avoid the occurrence of the disease.
なお、会合体の平均粒径も0.1ミクロン以下と小さい
ために注射剤としての応用も期待できる。Furthermore, since the average particle size of the aggregate is as small as 0.1 micron or less, it is also expected to be applied as an injection.
また、水性であるために、べとつがず、さっばりとした
使用域があり、両親媒性物質にレシチンを用いた場合に
は、レシチン自身の保湿効果、更に他の保湿効果を有す
る油分を保持させることにより高い保湿効果を与えるこ
とができるので、請求項4に記載された化粧品、医薬部
外品、医薬品などの優れた外用剤を提供出来る。In addition, since it is water-based, it is not sticky and has a light feel, and when lecithin is used as an amphipathic substance, it has a moisturizing effect as well as oils that have other moisturizing effects. By retaining it, a high moisturizing effect can be imparted, so that excellent external preparations such as cosmetics, quasi-drugs, and pharmaceuticals as described in claim 4 can be provided.
特許出願人 株式会社 資 生 堂Patent applicant: Shiseido Co., Ltd.
Claims (4)
む透明組成物。(1) A transparent composition containing an amphipathic substance, a surfactant, an oily component, and water.
合物に強力な剪断力処理をして成る請求項1記載の透明
組成物。(2) The transparent composition according to claim 1, which is obtained by subjecting a mixture of an amphiphilic substance, a surfactant, an oily component, and water to a strong shear force treatment.
性剤を含む請求項1記載の透明組成物。(3) The transparent composition according to claim 1, which contains 10 parts by weight or less of a surfactant per 1 part by weight of the oily component.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14995989A JP3298867B2 (en) | 1988-06-20 | 1989-06-13 | Transparent composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15019588 | 1988-06-20 | ||
JP63-150195 | 1988-06-20 | ||
JP14995989A JP3298867B2 (en) | 1988-06-20 | 1989-06-13 | Transparent composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0278432A true JPH0278432A (en) | 1990-03-19 |
JP3298867B2 JP3298867B2 (en) | 2002-07-08 |
Family
ID=26479696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14995989A Expired - Fee Related JP3298867B2 (en) | 1988-06-20 | 1989-06-13 | Transparent composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3298867B2 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0892059A (en) * | 1994-09-20 | 1996-04-09 | Shiseido Co Ltd | Transparent face lotion |
JPH09301844A (en) * | 1996-03-12 | 1997-11-25 | Shiseido Co Ltd | Solubilized cosmetic material |
JP2000191443A (en) * | 1996-01-03 | 2000-07-11 | L'oreal Sa | Aqueous composition containing at lest one non-coated pigment and nonionic lipid microsome dispersed in aqueous phase and preparation thereof |
JP2002338499A (en) * | 2001-05-17 | 2002-11-27 | Bs Lab:Kk | Skin care preparation for external use |
JP2003342126A (en) * | 2002-05-27 | 2003-12-03 | Q P Corp | Transparent cosmetic |
JP2005263793A (en) * | 2004-02-18 | 2005-09-29 | Rohto Pharmaceut Co Ltd | Skin lotion |
US7297717B2 (en) | 2000-04-27 | 2007-11-20 | Kao Corporation | Emulsion cosmetic |
EP1927287A1 (en) | 2006-12-01 | 2008-06-04 | FUJIFILM Corporation | Emulsion composition, and foods and cosmetics containing the emulsion composition |
JP2008531682A (en) * | 2005-02-28 | 2008-08-14 | ソンヒョン チェ | Compositions that reduce leaching of serum proteins |
JPWO2006118246A1 (en) * | 2005-04-28 | 2008-12-18 | 独立行政法人科学技術振興機構 | Transdermal absorption enhancer |
JP2010511032A (en) * | 2006-11-29 | 2010-04-08 | マルベルン コスメセウチクス リミテッド | Composition comprising a polymer aggregate of lipid and surfactant |
JP2012201677A (en) * | 2011-03-28 | 2012-10-22 | Shiseido Co Ltd | Liquid composition, and transparent or semitransparent aqueous composition using the same |
WO2015136783A1 (en) * | 2014-03-14 | 2015-09-17 | 富士フイルム株式会社 | Dispersion composition and cosmetic material |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5348784B2 (en) | 2009-12-28 | 2013-11-20 | 株式会社 資生堂 | Cosmetics |
-
1989
- 1989-06-13 JP JP14995989A patent/JP3298867B2/en not_active Expired - Fee Related
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0892059A (en) * | 1994-09-20 | 1996-04-09 | Shiseido Co Ltd | Transparent face lotion |
JP2000191443A (en) * | 1996-01-03 | 2000-07-11 | L'oreal Sa | Aqueous composition containing at lest one non-coated pigment and nonionic lipid microsome dispersed in aqueous phase and preparation thereof |
JPH09301844A (en) * | 1996-03-12 | 1997-11-25 | Shiseido Co Ltd | Solubilized cosmetic material |
US7297717B2 (en) | 2000-04-27 | 2007-11-20 | Kao Corporation | Emulsion cosmetic |
JP2002338499A (en) * | 2001-05-17 | 2002-11-27 | Bs Lab:Kk | Skin care preparation for external use |
JP2003342126A (en) * | 2002-05-27 | 2003-12-03 | Q P Corp | Transparent cosmetic |
JP2005263793A (en) * | 2004-02-18 | 2005-09-29 | Rohto Pharmaceut Co Ltd | Skin lotion |
JP2008531682A (en) * | 2005-02-28 | 2008-08-14 | ソンヒョン チェ | Compositions that reduce leaching of serum proteins |
US8853195B2 (en) | 2005-02-28 | 2014-10-07 | Kt & G Corporation | Composition for reducing the exudation of serum proteins |
JPWO2006118246A1 (en) * | 2005-04-28 | 2008-12-18 | 独立行政法人科学技術振興機構 | Transdermal absorption enhancer |
US9095560B2 (en) | 2005-04-28 | 2015-08-04 | Japan Science And Technology Agency | Method of enhancing transdermal absorption using a composition comprising POE octyl dodecyl ether and squalane |
JP2010511032A (en) * | 2006-11-29 | 2010-04-08 | マルベルン コスメセウチクス リミテッド | Composition comprising a polymer aggregate of lipid and surfactant |
JP2015110569A (en) * | 2006-11-29 | 2015-06-18 | マルベルン コスメセウチクス リミテッド | Compositions comprising macromolecular assemblies of lipid and surfactant |
EP1927287A1 (en) | 2006-12-01 | 2008-06-04 | FUJIFILM Corporation | Emulsion composition, and foods and cosmetics containing the emulsion composition |
JP2012201677A (en) * | 2011-03-28 | 2012-10-22 | Shiseido Co Ltd | Liquid composition, and transparent or semitransparent aqueous composition using the same |
WO2015136783A1 (en) * | 2014-03-14 | 2015-09-17 | 富士フイルム株式会社 | Dispersion composition and cosmetic material |
JPWO2015136783A1 (en) * | 2014-03-14 | 2017-04-06 | 富士フイルム株式会社 | Dispersion composition and cosmetics |
Also Published As
Publication number | Publication date |
---|---|
JP3298867B2 (en) | 2002-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU611302B2 (en) | Transparent composition | |
JP3398171B2 (en) | Oil-in-water emulsion composition | |
JP4972553B2 (en) | Process for producing microemulsion and submicron emulsion and composition | |
JP5508682B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
KR101116899B1 (en) | Concentrated and diluted stable oil/water emulsions | |
JP2007522205A (en) | Multilamellar liposome and production method thereof | |
JPH0278432A (en) | Transparent composition | |
JPH0774145B2 (en) | Emulsion composition containing crystalline drug | |
JP2003212716A (en) | Liquid crystalline emulsion composition | |
JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
JP4049216B2 (en) | Formulation with liquid crystal structure | |
KR20220091739A (en) | Translucent nanoemulsion containing natural ceramide and cosmetic composition including the same | |
JPH07267814A (en) | Toilet water type emulsified composition | |
JP2002338499A (en) | Skin care preparation for external use | |
JP5134197B2 (en) | Oil-in-water microemulsion and process for producing the same | |
JP3535583B2 (en) | Clear lotion | |
JP3752767B2 (en) | High oil content oil-in-water emulsified composition and method for producing the same | |
KR100654844B1 (en) | Cosmetic composition having a nano-size phospholipid emulsion of oil in water type using a hydrophobically modified polyfroctose polymeric emulsifier and manufacturing method thereof | |
JPH09132512A (en) | Lamellar structure of sterol fatty acid ester | |
JP4590067B2 (en) | Emulsified composition | |
JPH03106812A (en) | Low-irritant composition for injection | |
JP2002193790A (en) | Oil-in-water type emulsion containing scarcely water- soluble drug and method of producing the same | |
JPH11130615A (en) | Production of liposome dispersion and cosmetic using the same | |
KR20140117042A (en) | Lipasome capsule composition containing lipoamino acids, manufacturing method thereof and cosmetic composition using the same | |
JPH08245370A (en) | O/w-type emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090419 Year of fee payment: 7 |
|
LAPS | Cancellation because of no payment of annual fees |